Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp reaffirms FY 2017 revenue guidance - Conference Call


Wednesday, 11 Jun 2014 01:00pm EDT 

Celgene Corp:Expects FY 2017 revenue of $13 billion to $14 billion overall.FY 2017 revenue of $13 billion - Thomson Reuters I/B/E/S. 

Company Quote

92.25
-0.32 -0.35%
17 Sep 2014